Clinical Trial Update: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) [Phase 2]

View source ↗

Summary

A Phase 2 trial of temozolomide in pre-selected advanced aerodigestive tract cancers was terminated; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colorectal Neoplasm, Head and Neck Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2010-07-05